JPRN-jRCT2080222380未知3 期
An Extension Study of KHK4827 Subjects with Plaque Psoriasis (Psoriasis Vulgaris, Psoriatic Arthritis), Pustular Psoriasis (Generalized) and Psoriatic Erythroderma
Kyowa Hakko Kirin Co., Ltd.0 个研究点目标入组 165 人开始时间: 2014年1月31日最近更新:
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 165
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Subject has voluntarily signed the written informed consent form to particiate in this study
- •-Subject has completed the week 52 evaluation of Study 003 or 004.
排除标准
- •-Subject has had a serious infection, defined as requireing systemic treatment with antibiotics or antivirals (excluding oral administration)
- •-Subject has been judged to be ineligible for participation in the study by the investigators/subinbestigators
研究者
相似试验
未知
3 期
An open-label, non-controlled study of KHK4827 in subjects with psoriasisJPRN-jRCT2080222011Kyowa Hakko Kirin Co., Ltd.
已完成
3 期
A Phase 3 Clinical Study of KHK 4827Psoriatic ErythrodermaPsoriasis, Palmaris Et Plantaris PustularPsoriatic ArthritisPsoriasis VulgarisNCT02052609Kyowa Kirin Co., Ltd.155
已完成
3 期
An Open-label, Non-controlled Study of KHK4827 in Subjects With PsoriasisPsoriasisNCT01782937Kyowa Kirin Co., Ltd.30
进行中（未招募）
1 期
Phase 2 Study of HKI-272 in Subjects with Advanced Breast CancerEUCTR2005-003098-26-FRWyeth Research Division of Wyeth Pharmaceuticals Inc.122
已完成
2 期
A clinical trial to study the effect of HKI-272 in subjects with Advanced breast cancerCTRI/2009/091/000817Wyeth Research Wyeth Pharmaceuticals India Private Limited A Subsidiary of Pfizer Inc137